Rare, Pediatric Drug Development and Reimbursement Boosted In Shaky US Spending Deal

 
• By Sarah Karlin-Smith
  
Little girl at doctor's appointment.
Rare and pediatric disease drug development and coverage may get a late 2024 boost from Congress. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legislation

More from Advanced Technologies